EUVIMEDEUVIMED entdecken
Crossref

Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum , and Synergize with Clinical Antimalarials

John Okombo, Malkeet Kumar, Devasha Redhi, Kathryn J Wicht iD, Lubbe Wiesner, Timothy J Egan iD, Kelly Chibale iD

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.2c00592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von John Okombo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Cape Town, Rondebosch, 7701 Cape Town, South Africa. Hauptthemen laut MEDLINE: Antimalarials. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: University of Cape Town, National Research Foundation, South African Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsAnimalsMicePlasmodium falciparumChloroquineHemeHemeproteins

Stichwörter der Autor:innen

Plasmodium falciparumchloroquinedibenzylmethylaminehERG inhibitionhemeprimary metabolites

Substanzen

AntimalarialsChloroquineHemehemozoinHemeproteins

Autor:innen und Institutionen

  • Department of Chemistry, University of Cape Town, Rondebosch, 7701 Cape Town, South Africa.
  • Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, 7925 Cape Town, South Africa.
  • South African Medical Research Council Drug Discovery and Development Research Unit, Holistic Drug Discovery and Development (H3D) Centre, Rondebosch, 7701 Cape Town, South Africa.
  • Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, 7701 Cape Town, South Africa.

ORCID-Profile: Kathryn J Wicht, Timothy J Egan, Kelly Chibale

Förderung

  • University of Cape Town
  • National Research Foundation
  • South African Medical Research Council

Zitieren

APA

Okombo, J., Kumar, M., Redhi, D., Wicht, K. J., Wiesner, L., Egan, T. J., & Chibale, K. (2023). Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum , and Synergize with Clinical Antimalarials. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.2c00592

Vancouver

Okombo J, Kumar M, Redhi D, Wicht KJ, Wiesner L, Egan TJ, et al. Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum , and Synergize with Clinical Antimalarials. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.2c00592

BibTeX
@article{Okombo2023,
  author = {Okombo, John and Kumar, Malkeet and Redhi, Devasha and Wicht, Kathryn J and Wiesner, Lubbe and Egan, Timothy J and Chibale, Kelly},
  title = {Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum , and Synergize with Clinical Antimalarials},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.2c00592}
}
Kostenlos starten →